Releases - Novozymes A/S

View:
 

Found press releases

 

Updated Financial calendar 2013

4/30/2013 8:00 AM EST
Novozymes A/S Financial Calendar Updated Financial calendar 2013 Novozymes hereby publishes its updated financial calendar for the remainder of Fiscal year 2013 Read the full announcement in PDF format.

Interim report for the first 3 months of 2013

4/25/2013 2:00 AM EST
Novozymes A/S
Quarterly report

Interim report for the first 3 months of 2013

First quarter as expected; full-year outlook maintained

The first quarter of 2013 was in line with expectations. Organic sales growth
was 5% (4% DKK, 5% LCY) compared with Q1 2012. EBIT grew by 4%, and the EBIT
margin was 24.9% – on par with the first quarter of 2012. The outlook for full
year 2013 is maintained on all lines with...

Reduction of share capital

4/5/2013 5:27 AM EST
Novozymes A/S Changes in share capital and votes Reduction of share capital With reference to company announcement no. 15/2013, a reduction of the company's B share capital, was adopted at Novozymes A/S' Annual Shareholders' Meeting on February 28, 2013. Read the full announcement in PDF format.

Trading by management in Novozymes A/S B Shares

3/1/2013 6:09 AM EST
Novozymes A/S Insiders' dealing Trading by management in Novozymes A/S B Shares In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B. Read the full announcement in PDF format.

Novozymes A/S Annual Shareholders’ Meeting 2013

2/28/2013 12:31 PM EST
Novozymes A/S Decisions of annual general meeting Novozymes A/S Annual Shareholders’ Meeting 2013 Novozymes A/S today held its Annual Shareholders' Meeting Read the full announcement in PDF format.

Acquisition of the enzymes business of Iogen Corporation completed

2/22/2013 2:30 AM EST
Novozymes A/S Company Announcement Acquisition of the enzymes business of Iogen Corporation completed In reference to company announcement no. 4 of January 31, 2013, the closing conditions for the transaction have been met, and the acquisition of the enzymes business of Iogen Corporation by Novozymes has been completed. Read the announcement in PDF format.

Trading by management in Novozymes A/S B Shares

2/18/2013 3:23 AM EST
Novozymes A/S Insiders' dealing Trading by management in Novozymes A/S B Shares In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B. Read the full announcement in PDF format.

Trading by management in Novozymes A/S B Shares

2/15/2013 4:51 AM EST
Novozymes A/S Insiders' dealing Trading by management in Novozymes A/S B Shares In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B. Read the full announcement in PDF format.

Trading by management in Novozymes A/S B Shares

2/14/2013 3:30 AM EST
Novozymes A/S Insiders' dealing Trading by management in Novozymes A/S B Shares In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B. Read the full announcement in PDF format.

Trading by management in Novozymes A/S B Shares

2/12/2013 4:13 AM EST
Novozymes A/S Insiders' dealing Trading by management in Novozymes A/S B Shares In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B. Read the full announcement in PDF format.

Novozymes A/S

RSS